RT Book, Section
A1 Baldwin, Andrew C. W.
A1 Gemmato, Courtney J.
A1 Cohn, William E.
A1 Frazier, O. H.
A2 Cohn, Lawrence H.
A2 Adams, David H.
SR Print(0)
ID 1144168648
T1 Long-term Mechanical Circulatory Support and the Total Artificial Heart
T2 Cardiac Surgery in the Adult, 5e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071844871
LK accesscardiology.mhmedical.com/content.aspx?aid=1144168648
RD 2024/04/19
AB Heart  failure  (HF)  is  a  leading  cause  of  death  in  the  United  States  and  a  significant  public  health  concern  throughout  the  world.  Results  from  the  Framingham  Heart  Study  suggest  that  the  lifetime  risk  of  developing  HF  for  Americans  over  the  age  of  40  years  is  approximately  20%,  and  the  incidence  of  this  disease  steadily  increases  with  age.1  An  estimated  5.1  million  Americans  are  living  with  HF.  This  figure  is  expected  to  grow  significantly  in  the  coming  decades  because  the  average  age  of  the  population  is  increasing,  and  advancements  in  medical  therapy  are  allowing  patients  to  live  longer  with  their  disease.2,3  The  economic  burden  of  disease  is  also  high,  and  total  healthcare  costs  attributed  to  HF  exceed  $30  billion  in  the  United  States  each  year.2,3  In  light  of  the  increased  mortality  associated  with  HF,  strategies  for  managing  this  disease  have  grown  increasingly  sophisticated.